Merck Agreed to Purchase Imago BioSciences to Gain Therapies for Bone Marrow Conditions ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Merck agreed to purchase Imago BioSciences to gain therapies for bone marrow conditions that lead to overproduction of blood cells, including one drug in mid-stage trials ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)